fda compounding glp-1 enforcement news today Medvi Warning Exposes Gaps Compounded Semaglutide & Tirzepatide 2025:

If they are severe or persistent, they warrant contact with your prescribing provider

The GLP-1 is released upon food consumption in a biphasic pattern with an early phase 1015 min and a longer second phase 3060 min after meal

Average weight loss at six months is approximately 12 to 15% of starting body weight with semaglutide 2.4mg and 15 to 19% with tirzepatide at higher doses

The only way to find the right tirzepatide dose for someone coming from semaglutide is to start low and observe, which is exactly what every switching protocol recommends

The unprecedented demand for prescription drugs, specifically GLP-1 receptor agonists (GLP-1s), for type 2 diabetes and obesity has gained significant attention

Results based on a January 2026 analysis of 14,203 Noom GLP-1Rx Program members who actively logged weight over a 40 week period